Market revenue in 2022 | USD 1,852.2 million |
Market revenue in 2030 | USD 2,801.4 million |
Growth rate | 5.3% (CAGR from 2022 to 2030) |
Largest segment | Reagents & consumables |
Fastest growing segment | Analyzers |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Analyzers, Reagents & Consumables |
Key market players worldwide | BioMerieux SA, Roche Holding AG, Siemens Healthineers AG ADR, Abbott Laboratories, Horiba Ltd, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Biomedica Diagnostics, Werfen, Diazyme Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thrombosis and hemostasis biomarkers market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 65.6% in 2022. Horizon Databook has segmented the North America thrombosis and hemostasis biomarkers market based on analyzers, reagents & consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The North America market consists of the U.S. and Canada. The region held the largest share of 36.99% in 2022. The increasing prevalence of thrombosis and hemostasis disorders, advancements in technology, and consistent R&D efforts in biomarkers are key factors driving the market in the region.
For instance, the estimated annual incidence of Venous Thromboembolism (VTE) in the region ranges from 104 to 183 cases per 100,000 population per year. The rising awareness among people for early diagnosis and treatment is also a major factor contributing to the market growth.
The U.S. dominates the regional market due to the high prevalence of these disorders, strong focus on R&D & investments in biomarkers, and the well-established healthcare system. Key players operating in the North America thrombosis and hemostasis biomarkers market include Abbott, F Hoffmann-La Roche Ltd., Siemens Healthineers, Bio-Rad Laboratories, and Thermo Fisher Scientific.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America thrombosis and hemostasis biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into North America thrombosis and hemostasis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account